Gen-Probe To Pay $22.5M To Settle Patent Dispute With Abbott Unit
Gen-Probe will pay $22.5 million to eliminate future royalty payments and settle its patent litigation against Abbott Laboratories unit Vysis, Inc. over products for clinical diagnostics and blood screening, the company...To view the full article, register now.
Already a subscriber? Click here to view full article